To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Similar rate of success in Dupuytren contracture treatment between collagenase and needle fasciotomy

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Author Verified
Ace Report Cover
October 2018

Similar rate of success in Dupuytren contracture treatment between collagenase and needle fasciotomy

Vol: 7| Issue: 10| Number:15| ISSN#: 2564-2537
Study Type:Randomized Trial
OE Level Evidence:2
Journal Level of Evidence:N/A

Percutaneous Needle Fasciotomy Versus Collagenase Treatment for Dupuytren Contracture: A Randomized Controlled Trial with a Two-Year Follow-up

J Bone Joint Surg Am. 2018 Jul 5;100(13):1079-1086

Contributing Authors:
J Strömberg A Ibsen-Sörensen J Fridén

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

156 patients with Dupuytren contracture of the metacarpophalangeal joint, with or without proximal interphalangeal joint involvement, were randomized to treatment with either collagenase Clostridium histolyticum (CCH) injection or percutaneous needle fasciotomy (PNF). Patients were followed-up for 2 years following treatment. Results demonstrated no significant differences between groups over 2 ye...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue